Literature DB >> 23100950

Interstitial deletion of 9q in a case of acute myeloid leukemia with t(8;21).

B Kar1, K G Dhanalakshmi, R Revathi.   

Abstract

Entities:  

Year:  2008        PMID： 23100950      PMCID： PMC3453036          DOI： 10.1007/s12288-008-0034-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  6 in total

1.  Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.

Authors:  J D Rowley
Journal:  Ann Genet       Date:  1973-06

2.  A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.

Authors:  K Wheatley; A K Burnett; A H Goldstone; R G Gray; I M Hann; C J Harrison; J K Rees; R F Stevens; H Walker
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

3.  Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.

Authors:  C Schoch; D Haase; T Haferlach; H Gudat; T Büchner; M Freund; H Link; E Lengfelder; H Wandt; M C Sauerland; H Löffler; C Fonatsch
Journal:  Leukemia       Date:  1996-08       Impact factor: 11.528

4.  Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.

Authors:  D K Kalwinsky; S C Raimondi; M J Schell; J Mirro; V M Santana; F Behm; G V Dahl; D Williams
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

5.  Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Français de Cytogénétique Hématologique.

Authors: 
Journal:  Cancer Genet Cytogenet       Date:  1990-02

6.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113
  6 in total
  1 in total

1.  A Case of AML-M2 with Sole Interstitial Deletion in 9q Without AML1-ETO/Inv 16 Rearrangement and FLT3/NPMI Mutations.

Authors:  G Sandhya Devi; Faiq Ahmed; Manasi C Mundada; S Sudha Murthy; Krishna Mohan Mallavarapu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-23       Impact factor: 0.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.